Anti-Fibrotic Effects Of Nintedanib (bibf 1120) In Primary Human Lung Fibroblasts Derived From Patients With Idiopathic Pulmonary Fibrosis And From Non-Fibrotic Controls

被引：0
|
作者：
Hostettler, K. E. [1 ]
Papakonstantinou, E. [2 ]
Klagas, J. [2 ]
Karakiulakis, G. [2 ]
Zhong, J. [1 ]
Tamm, M. [1 ]
Lardinois, D. [1 ]
Roth, M. [1 ]
机构：
[1] Univ Basel Hosp, Basel, Switzerland
[2] Univ Thessaloniki, Thessaloniki, Greece
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3374
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A review of Idiopathic Pulmonary Fibrosis patients on anti-fibrotic treatment in the mid west area
    Ryan, N.
    Ryan, P.
    Gleeson, E.
    Cullinan, M.
    Mcinerney, C.
    Casserly, B.
    O'Brien, A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (SUPPL 10) : S441 - S442
  • [22] LSC Abstract - A human lung explant model of fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
    Roach, Katy
    Newby, Chris
    Amrani, Y.
    Bradding, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [23] LSC Abstract - A human lung explant model of fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
    Roach, Katy
    Newby, Chris
    Amrani, Y.
    Bradding, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [24] Effect Of Nintedanib On Pro-Fibrotic And Anti-Fibrotic Cytokine Release From Alveolar Macrophages In Interstitial Lung Diseases
    Bonella, F.
    Long, X.
    He, X.
    Theegarten, D.
    Wessendorf, T. E.
    Guzman, J.
    Costabel, U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [25] Clinical Characteristics of Progressive Pulmonary Fibrosis of Idiopathic Pulmonary Fibrosis Patients Who Receive Anti-fibrotic Agent
    Kishaba, T.
    Nagano, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [26] Impact of an interstitial lung diseases Nurse on the compliance to anti-fibrotic drugs in patients with Idiopathic Pulmonary Fibrosis.
    Mendoza, Onofre Moran
    Aldhaheri, Sharina
    Mccarthy, Lynda
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [27] Nintedanib Attenuates Motility Of Lung Fibroblasts From Patients With Idiopathic Pulmonary Fibrosis
    Wollin, L.
    Ostermann, A.
    Wex, E.
    Herrmann, F. E.
    Doods, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [28] Cyclosporin A has anti-fibrotic effects in human lung fibroblasts and in bleomycin-induced lung fibrosis model mice
    Yamazaki, Risa
    Fujita, Tetsuo
    Yanagihara, Madoka
    Nakamura, Hiroyuki
    Fujino, Hiromichi
    Kasuya, Yoshitoshi
    Murayama, Toshihiko
    FASEB JOURNAL, 2016, 30
  • [29] Cyclosporin A has anti-fibrotic effects in human lung fibroblasts and in bleomycin- induced lung fibrosis model mice
    Yamazaki, Risa
    Fujita, Tetsuo
    Yanagihara, Madoka
    Nakamura, Hiroyuki
    Fujino, Hiromichi
    Kasuya, Yoshitoshi
    Murayama, Toshihiko
    FASEB JOURNAL, 2016, 30
  • [30] Effect of nintedanib on hyaluronic acid metabolism in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin
    Papakonstantinou, Eleni
    Klagas, Ioannis
    Bonovolias, Ioannis
    Tamm, Michael
    Lambers, Christopher
    Lardinois, Didier
    Roth, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
12345